A targeting vector was designed to disrupt the first ATG of transcript variants 1-3 and replace the promoter of variant 4 by the insertion of a neo in the ATG in exon 3. In testes, a truncated Tdrd1 mRNA was detected, but Western blot analysis showed absence of any Tdrd1 protein.